How Does the Urea Breath Test Work for H. pylori?

The urea breath test is a quick, noninvasive way to find out whether you have an active Helicobacter pylori infection in your stomach. You swallow a small capsule or drink containing urea labeled with a traceable form of carbon, then breathe into a collection device about 15 to 30 minutes later. If H. pylori is present, enzymes produced by the bacterium break down the labeled urea, and the telltale carbon shows up in your breath. Across multiple large analyses, the test consistently achieves sensitivity and specificity above 90%, which is why major international guidelines treat it as the preferred noninvasive diagnostic method for this infection.

How the Test Actually Works

The principle behind the urea breath test hinges on one distinctive trait of H. pylori: the bacterium produces large amounts of an enzyme called urease. Urease breaks urea into ammonia and carbon dioxide. Under normal circumstances, the tiny amount of urea that reaches your stomach lining would not generate a meaningful burst of CO₂. But when H. pylori colonies are living in the stomach’s mucus layer, their urease rapidly splits the labeled urea you swallowed. The resulting labeled CO₂ passes through the stomach wall, enters the bloodstream, travels to the lungs, and exits in your breath.¹ A lab instrument then measures how much of the labeled carbon is in the breath sample compared to a baseline sample taken before you swallowed the urea. If the increase exceeds a specific threshold, the test is positive.

You may be asked to drink a small amount of citric acid solution or eat a light citric acid-based test meal shortly before or alongside the labeled urea. The acid slows gastric emptying, keeping the urea in contact with the stomach lining longer and distributing it more evenly, which enhances the signal from any urease activity present.² Some protocols skip the citric acid, but those that include it tend to produce more consistent results.

Carbon-13 Versus Carbon-14

There are two versions of the test, distinguished by the type of carbon isotope used to label the urea. Carbon-13 is a stable, nonradioactive isotope that occurs naturally in tiny amounts. Carbon-14 is mildly radioactive. Both versions perform well, but the choice between them has practical consequences.

Carbon-14 tests are generally cheaper and the breath sample can be analyzed with a relatively simple scintillation counter. Carbon-13 tests require either isotope ratio mass spectrometry or infrared spectrometry, instruments that are more expensive but increasingly available as desktop units. Because carbon-13 involves no radiation at all, it is the preferred choice for children, pregnant women, and anyone for whom even minimal radiation exposure is best avoided. In practice, both isotopes offer high sensitivity and specificity, so the decision often comes down to cost, equipment availability, and patient population.

How Accurate Is It

The urea breath test is one of the most accurate noninvasive tests for H. pylori. A meta-analysis pooling data from multiple studies found pooled sensitivity of 96% and specificity of 93%, with the area under the curve reaching 0.985.³ A separate meta-analysis focusing on Asian populations reported even tighter numbers for the carbon-13 version, with sensitivity of 97% and specificity of 96%.⁴ A third meta-analysis covering both isotope types found somewhat lower pooled figures, around 88–93% for sensitivity and 85–90% for specificity depending on the statistical model used, and noted significant variability between individual studies.⁵

The spread in those numbers reflects real-world differences in study design, patient populations, and cutoff values rather than a fundamental weakness of the test. Across the board, the evidence confirms that the urea breath test reliably catches active infections and rarely flags people who are uninfected. The Maastricht VI/Florence consensus, the most influential European guideline on H. pylori management, identifies the urea breath test as the best noninvasive approach for diagnosis within a “test-and-treat” strategy.⁶

How It Compares to Other Tests

H. pylori can be detected by several methods, and the breath test is not the only good option. The stool antigen test is the other major noninvasive choice, and in head-to-head comparisons the two often trade places in performance. One prospective study found the breath test’s sensitivity ranged from about 89% to 98% depending on the reference standard, with specificity above 98%, closely matching histology and the rapid urease test performed on biopsy samples taken during endoscopy.⁷ Serology, which measures antibodies in the blood, consistently underperforms by comparison because it cannot distinguish between a current infection and one that was cleared years ago.

Endoscopy-based tests (histology and the rapid urease test on a biopsy sample) are highly accurate but require an invasive procedure. For most patients with uncomplicated symptoms, guidelines prefer the breath test or stool antigen test first, reserving endoscopy for situations where a visual look at the stomach is clinically necessary, such as in older patients or those with alarm symptoms like unexplained weight loss or difficulty swallowing.

Medications That Can Wreck the Results

The single biggest practical pitfall of the urea breath test is that certain medications suppress H. pylori without fully eradicating it, driving the bacterial load low enough to produce a negative result even though the infection is still there. Proton pump inhibitors are the main culprits. In one study, false-negative results occurred in 45% of infected patients after four weeks on a high dose of omeprazole.⁸ That is a strikingly high miss rate for an otherwise excellent test.

The mechanism appears to be a direct antibacterial effect of the PPI on H. pylori rather than simply a change in stomach acidity. Research into the timing of PPI withdrawal found that three days off the medication is the absolute minimum before testing, but a 14-day washout is preferred to minimize the chance of a false negative.⁹ Antibiotics and bismuth-containing medications (like Pepto-Bismol) can cause the same problem, so guidelines typically recommend stopping antibiotics and bismuth at least four weeks before a breath test and stopping PPIs at least two weeks before.

If you are taking a PPI for acid reflux and your doctor wants to test for H. pylori, you will need to plan the timing carefully. Stopping a PPI abruptly can cause a temporary rebound in acid production that makes symptoms worse for a few days, so your doctor may switch you to a simple antacid or H2 blocker in the interim. H2 blockers have a much smaller effect on breath test accuracy than PPIs do.

False Positives and What Causes Them

False negatives from PPIs get most of the attention, but false positives happen too, though they are rarer. In a study of 102 patients, four had false-positive results traced to urease-producing bacteria other than H. pylori colonizing the mouth or stomach. The culprits included species like Proteus mirabilis, Klebsiella pneumoniae, and Staphylococcus aureus.¹⁰ These organisms can split urea the same way H. pylori does, generating a labeled CO₂ signal that looks like an infection. This is uncommon in people with normal stomach acid, because most non-H. pylori bacteria cannot survive the acidic environment. But in patients on long-term acid-suppressing therapy or those who have had partial stomach surgery, bacterial overgrowth in the stomach becomes more plausible, and with it the chance of a misleading positive result.

Checking Whether Treatment Worked

After you finish a course of H. pylori eradication therapy, your doctor needs to confirm the bacteria are actually gone. The urea breath test is the most commonly used tool for this confirmation step. Timing matters here as well. One study found that a breath test performed as early as two weeks after finishing treatment yielded sensitivity of 90%, specificity of 99%, and overall accuracy of 97%, comparable to tests done at the more traditional four-to-six-week mark.¹¹ Still, most guidelines recommend waiting at least four weeks after completing antibiotics before retesting, both to allow the medication washout discussed earlier and to give any suppressed bacteria a chance to regrow to detectable levels if they survived.

In a recent study examining post-treatment outcomes, about 76% of patients had negative breath test results after first-line eradication therapy, indicating successful clearance, while roughly 24% still tested positive, signaling treatment failure.¹² Those patients typically move on to a second-line regimen with different antibiotics, followed by another breath test to verify success. This cycle of treat-then-confirm can repeat, but most infections are cleared within one or two rounds.

The Test During Active Bleeding

One clinical scenario where the breath test gets complicated is peptic ulcer bleeding. When a patient arrives at the emergency department with a bleeding ulcer, knowing whether H. pylori is behind it matters for treatment decisions. A systematic review found that the breath test maintains high accuracy even in this setting, with pooled sensitivity of 93% and specificity of 92%.¹³

However, testing very early during a hospital stay seems to lower reliability. One study of 131 hospitalized patients with ulcer bleeding found that 86% tested positive on the first breath test, but among those who initially tested negative, 83% turned positive when retested later.¹⁴ The main factor associated with a false negative was simply that the test was done too soon after admission. Blood in the stomach, medications given during resuscitation, and the physiological stress of active bleeding all seem to interfere. For this reason, a negative result obtained right after an emergency endoscopy should be interpreted cautiously, and retesting once the patient stabilizes is standard practice.

The Test in Children

The urea breath test works in children, but with some caveats. A systematic review and meta-analysis of pediatric studies found that the carbon-13 version had good overall accuracy, with sensitivity around 96% and specificity around 96% across all ages combined. In children older than six, the numbers were even better, reaching about 97% sensitivity and 98% specificity. In children six and younger, accuracy dipped by a few percentage points, with specificity dropping to around 94%.¹⁵ The slightly lower performance in younger children appears to be related to differences in gastric physiology and the practical difficulty of getting a small child to cooperate with the collection procedure. Adjusting the cutoff threshold and the dose of labeled urea can improve accuracy in this age group.

Safety is not a concern. A study evaluating point-of-care breath test devices in children found only one possibly related minor adverse event from the test substrate itself, with accuracy levels similar to those in adults.¹⁶ Because the carbon-13 version involves no radiation, it is universally preferred for pediatric use.

Understanding the Cutoff Number

When you get a breath test result, the lab reports a value called the delta over baseline, or DOB. This is the difference in the ratio of labeled carbon to regular carbon between your post-ingestion breath sample and your baseline sample. If the DOB exceeds a set threshold, the result is positive. If it falls below, it is negative.

The most commonly used manufacturer cutoff for the carbon-13 test is a DOB of 3.5 per mil at 30 minutes. But research suggests this threshold may not be perfect for everyone. A large referral-laboratory analysis of over 200,000 tests proposed a lower optimized cutoff of 2.74 DOB based on cluster analysis, which would reclassify a small number of previously negative patients as positive. The study also found that optimal cutoffs varied slightly by sex and age group.¹⁷ Among patients whose DOB fell in the grey zone between the new and old cutoffs, about half remained positive on follow-up testing months later, suggesting a real infection had been there all along.

An interesting newer finding from pediatric research is that DOB values may carry information beyond a simple yes-or-no diagnosis. A retrospective study of children found that higher DOB values correlated with greater risk of peptic ulcers, with ulcer risk rising as DOB increased up to a plateau.¹⁸ If validated in larger studies, quantitative DOB values could eventually help clinicians gauge the severity of infection, not just its presence.

Point-of-Care Testing in Your Doctor’s Office

Traditionally, breath samples were collected at a clinic and shipped to a central lab for analysis, adding days to the turnaround. Desktop infrared spectrometers have changed that. Studies of point-of-care testing found that clinic staff with no prior breath-testing experience could run the test and get results on site, with agreement rates above 99% compared to reference laboratory analysis.¹⁹²⁰ The ability to get a definitive answer during a single office visit removes the need for a follow-up appointment and lets treatment begin the same day if the test is positive. For patients who might not return for a second visit, that immediacy can be the difference between treating an infection and losing track of it.

Cost-Effectiveness of the Test-and-Treat Approach

One reason the breath test has become so central to H. pylori management is economics. The “test-and-treat” strategy, where patients with dyspepsia symptoms receive a breath test (or stool antigen test) and get treated if positive without undergoing endoscopy first, consistently comes out ahead in cost-effectiveness analyses. A UK modeling study found that both the stool antigen test and the breath test were cheaper and more effective than endoscopy for managing dyspepsia and preventing ulcers, with very similar cost-per-success ratios between the two noninvasive options.²¹ A Spanish analysis reached the same conclusion and extended it to gastric cancer prevention, finding the test-and-treat strategy the most cost-effective approach across all three endpoints: symptom relief, ulcer prevention, and cancer avoidance.²²

The savings come from avoiding unnecessary endoscopies. Endoscopy is more expensive, requires sedation and specialist time, and carries a small procedural risk. When a breath test can answer the diagnostic question just as reliably, reserving endoscopy for cases where it is truly needed saves money and spares patients an unpleasant procedure.

Detection Equipment Behind the Scenes

If you have a carbon-13 breath test, your sample will be analyzed by one of two technologies: isotope ratio mass spectrometry (IRMS) or nondispersive infrared spectrometry (NDIR). IRMS is the older, more established method and is considered the analytical gold standard. NDIR instruments are smaller, cheaper, and easier to maintain, which makes them practical for point-of-care use. Multiple comparison studies have confirmed that the two technologies agree closely. In one head-to-head comparison, the correlation between IRMS and infrared devices exceeded 0.96, with sensitivity ranging from 97% to 100% for both types, though specificity was marginally lower with infrared at one time point.²³ A second comparison study found similar concordance and diagnostic accuracy between the two methods.²⁴ From your perspective as a patient, it makes essentially no difference which machine reads your sample.

Breath Tests Beyond H. pylori

The urea breath test is the most well-known member of a broader family of carbon-13 breath tests used in gastroenterology. The same basic principle, swallow a labeled substance and measure what shows up in your breath, can be adapted to study very different questions depending on which substance is labeled. Carbon-13 breath tests exist for evaluating how quickly your stomach empties (using labeled octanoic acid baked into a muffin or egg yolk), how well your liver metabolizes certain compounds (using substrates that target specific liver enzyme pathways), and even pancreatic function.²⁵ Gastric emptying breath tests, for instance, produce results comparable to the traditional scintigraphy scan and can be useful in diagnosing gastroparesis without radiation exposure.²⁶ These related tests share the urea breath test’s practical advantages: they are noninvasive, radiation-free (when using carbon-13), and can be done in an outpatient setting. While they are less widely available than the H. pylori version, they represent a growing toolkit for diagnosing digestive conditions without endoscopy or imaging.